The Effect of Glaucoma Drops on of the Duration of a Pure Intraocular Gas Bubble

• Status: Completed
• Trial end date: 2013-04-01
• Target enrollment: 0
• Participant gender: All

Summary

A controlled clinical study comparing the effect of topical aqueous suppressants on intraocular gas duration.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Brian Burke, MPH; Jason Hsu, MD
• Treatments: Dorzolamide; Methylprednisolone; Methylprednisolone acetate; Methylprednisolone Hemisuccinate; Polymyxin B; Polymyxins; Prednisolone; Prednisolone acetate; Prednisolone hemisuccinate; Prednisolone phosphate; Timolol; Trimethoprim

Criteria

Inclusion Criteria:

• Ability to provide written informed consent and comply with study assessments for the full duration of the study.

• Have undergone eye surgery including scleral buckling or pneumatic retinopexy for treatment of retinal detachment other condition at the discretion of the investigator.

Exclusion Criteria:

• Prior surgery to treat glaucoma.

• Current use of glaucoma eye drops.

• Absence of a lens in the eye or presence of a lens implant in front of the iris (colored part of your eye).

• Allergy or contraindication to any of the glaucoma drops being used in this study (e.g., sulfa allergy, asthma, chronic obstructive pulmonary disease (bronchitis or emphysema), slow heart rate).